Zacks Investment Management’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-15,342
Closed -$1.15M 707
2017
Q1
$1.15M Buy
15,342
+740
+5% +$53.7K 0.03% 324
2016
Q4
$984K Sell
14,602
-5,669
-28% -$365K 0.03% 327
2016
Q3
$1.35M Buy
20,271
+1,180
+6% +$75.2K 0.04% 273
2016
Q2
$1.14M Sell
19,091
-9,851
-34% -$533K 0.03% 296
2016
Q1
$1.41M Sell
28,942
-1,657
-5% -$75.2K 0.04% 261
2015
Q4
$1.66M Buy
+30,599
New +$1.56M 0.05% 224
2014
Q2
Sell
-6,245
Closed -$240K 783
2014
Q1
$240K Buy
+6,245
New +$229K 0.01% 588

Other funds holding NUVA

Zacks Investment Management's NUVA Position: Q2 2017 in Review

Zacks Investment Management sold out of NuVasive, Inc. (NUVA) in Q2 2017, closing a stake of 15,342 shares — an estimated $1.15M sold.

Zacks Investment Management first reported a position in NUVA in Q1 2014 and held it in 7 quarters. The position peaked at $1.66M in Q4 2015. 298 funds tracked by Wall St. Rank hold NUVA as of Q2 2017.

  • Zacks Investment Management reported no remaining NuVasive, Inc. position as of Q2 2017 after selling out during the quarter.
  • Zacks Investment Management sold 15,342 NuVasive, Inc. shares in Q2 2017, an estimated $1.15M.
  • Zacks Investment Management first reported a position in NuVasive, Inc. in Q1 2014 and held it in 7 quarters.
  • Zacks Investment Management's NuVasive, Inc. position peaked at $1.66M in Q4 2015.
  • 298 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2017.

Based on Zacks Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.